Francesca Tronconi

Ancona, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study.

Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study.

Journal: The oncologist

Published: March 23, 2023

Lynch Syndrome and Gynecologic Tumors: Incidence, Prophylaxis, and Management of Patients with Cancer.

Lynch Syndrome and Gynecologic Tumors: Incidence, Prophylaxis, and Management of Patients with Cancer.

Journal: Cancers

Published: January 22, 2023

Recent progress in the use of pharmacotherapy for endometrial cancer.

Recent progress in the use of pharmacotherapy for endometrial cancer.

Journal: Expert opinion on pharmacotherapy

Published: August 01, 2022

Advanced and recurrent endometrial cancer: State of the art and future perspectives.

Advanced and recurrent endometrial cancer: State of the art and future perspectives.

Journal: Critical reviews in oncology/hematology

Published: April 15, 2022

Potential immune‑related adverse events during dabrafenib and trametinib treatment: A case series of patients with BRAF V600E melanoma.

Potential immune‑related adverse events during dabrafenib and trametinib treatment: A case series of patients with BRAF V600E melanoma.

Journal: Molecular and clinical oncology

Published: April 07, 2022

Combining PARP inhibition and immune checkpoint blockade in ovarian cancer patients: a new perspective on the horizon?

Combining PARP inhibition and immune checkpoint blockade in ovarian cancer patients: a new perspective on the horizon?

Journal: ESMO open

Published: March 17, 2022

PARP Inhibitors Resistance: Mechanisms and Perspectives.

PARP Inhibitors Resistance: Mechanisms and Perspectives.

Journal: Cancers

Published: February 07, 2022

Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives.

Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives.

Journal: Frontiers in oncology

Published: December 08, 2021

Management of stage III and IVa uterine cancer.

Management of stage III and IVa uterine cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: October 15, 2021

Potential benefit of β-glucans as adjuvant therapy in immuno-oncology: a review.

Potential benefit of β-glucans as adjuvant therapy in immuno-oncology: a review.

Journal: Exploration of targeted anti-tumor therapy

Published: October 23, 2020

Systemic treatment for lung carcinoids: from bench to bedside.

Systemic treatment for lung carcinoids: from bench to bedside.

Journal: Clinical and translational medicine

Published: April 14, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026